Answers are grounded in this paper and cite their sources.
Over the last decade, the proportion of female panelists in NCCN CPGPs has doubled, with more than 50% of members of 60 CPGPs in 2020 being women. In ESMO, although there was an increase in female representation in a few CPGPs from 2010 to 2020, overall female representation remains low (<30%). By continuing to examine these trends, we can create awareness and work toward developing appropriate targeted interventions to improve gender disparities in the major organizations that create CPGs for cancer care.
No takes yet. Share an insight, caveat, or question.
Madhuri Chengappa (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: